🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
16.48
-0.74 (-4.30%)
At close: Nov 20, 2026, 4:00 PM EST
16.50
+0.02 (0.12%)
After-hours: Nov 20, 2026, 7:31 PM EST

Ultragenyx Pharmaceutical Statistics

Total Valuation

RARE has a market cap or net worth of $1.67 billion. The enterprise value is $2.46 billion.

Market Cap1.67B
Enterprise Value 2.46B

Important Dates

The last earnings date was Tuesday, November 3, 2026, after market close.

Earnings Date Nov 3, 2026
Ex-Dividend Date n/a

Share Statistics

RARE has 101.62 million shares outstanding. The number of shares has increased by 3.70% in one year.

Current Share Class 101.62M
Shares Outstanding 101.62M
Shares Change (YoY) +3.70%
Shares Change (QoQ) +0.20%
Owned by Insiders (%) 3.49%
Owned by Institutions (%) 94.78%
Float 83.24M

Valuation Ratios

PE Ratio n/a
Forward PE 22.47
PS Ratio 2.29
Forward PS 1.75
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.37
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.40

Current Ratio 1.40
Quick Ratio 1.12
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.27

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -44.08%
Return on Invested Capital (ROIC) -32.20%
Return on Capital Employed (ROCE) -54.76%
Weighted Average Cost of Capital (WACC) 5.93%
Revenue Per Employee $532,458
Profits Per Employee -$382,203
Employee Count1,371
Asset Turnover 0.61
Inventory Turnover 14.53

Taxes

Income Tax -6.00M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -48.27% in the last 52 weeks. The beta is 0.36, so RARE's price volatility has been lower than the market average.

Beta (5Y) 0.36
52-Week Price Change -48.27%
50-Day Moving Average 15.51
200-Day Moving Average 22.34
Relative Strength Index (RSI) 50.64
Average Volume (20 Days) 3,958,708

Short Selling Information

The latest short interest is 23.62 million, so 23.25% of the outstanding shares have been sold short.

Short Interest 23.62M
Short Previous Month 20.15M
Short % of Shares Out 23.25%
Short % of Float 28.38%
Short Ratio (days to cover) 6.81

Income Statement

In the last 12 months, RARE had revenue of $730.00 million and -$524.00 million in losses. Loss per share was -$5.18.

Revenue730.00M
Gross Profit -78.00M
Operating Income -437.00M
Pretax Income -530.00M
Net Income -524.00M
EBITDA -403.00M
EBIT -437.00M
Loss Per Share -$5.18
Full Income Statement

Balance Sheet

The company has $401.00 million in cash and investments and $1.19 billion in debt, with a net cash position of -$785.00 million or -$7.72 per share.

Cash & Investments 401.00M
Total Debt 1.19B
Net Cash -785.00M
Net Cash Per Share -$7.72
Equity (Book Value) -369.00M
Book Value Per Share -3.70
Working Capital 155.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$437.00 million and capital expenditures -$5.00 million, giving a free cash flow of -$442.00 million.

Operating Cash Flow -437.00M
Capital Expenditures -5.00M
Depreciation & Amortization 34.00M
Net Borrowing n/a
Free Cash Flow -442.00M
FCF Per Share -$4.35
Full Cash Flow Statement

Margins

Gross margin is -10.68%, with operating and profit margins of -59.86% and -71.78%.

Gross Margin -10.68%
Operating Margin -59.86%
Pretax Margin -72.60%
Profit Margin -71.78%
EBITDA Margin -55.21%
EBIT Margin -59.86%
FCF Margin n/a

Dividends & Yields

RARE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -3.70%
Shareholder Yield n/a
Earnings Yield -31.43%
FCF Yield -26.39%

Analyst Forecast

The average price target for RARE is $24.80, which is 50.49% higher than the current price. The consensus rating is "Buy".

Price Target $24.80
Price Target Difference 50.49%
Analyst Consensus Buy
Analyst Count 21
Revenue Growth Forecast (3Y) 16.30%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RARE has an Altman Z-Score of -5.28 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.28
Piotroski F-Score 3